The New England journal of medicine

• Latest
• Best
• Search…

• N. Engl. J. Med. · Sep 2006

  Comment Letter

  Fluid-management strategies in acute lung injury.

  no abstract available

  explore more… mark as read…

• N. Engl. J. Med. · Sep 2006

  Comment Letter

  Fluid-management strategies in acute lung injury.

  no abstract available

  explore more… or not…

• N. Engl. J. Med. · Sep 2006

  Comment Letter

  Cyclophosphamide in scleroderma lung disease.

  no abstract available

  expand abstract… mark as read…

• N. Engl. J. Med. · Sep 2006

  Going beyond disease to address disability.

  no abstract available

  keep going… or not…

• N. Engl. J. Med. · Sep 2006

  Randomized Controlled Trial Multicenter Study

  DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

  Adjuvant cisplatin-based chemotherapy improves survival among patients with completely resected non-small-cell lung cancer, but there is no validated clinical or biologic predictor of the benefit of chemotherapy. ⋯ Patients with completely resected non-small-cell lung cancer and ERCC1-negative tumors appear to benefit from adjuvant cisplatin-based chemotherapy, whereas patients with ERCC1-positive tumors do not.

  explore more… or not…